These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21475574)

  • 1. Survival analysis: part 15 of a series on evaluation of scientific publications.
    Zwiener I; Blettner M; Hommel G
    Dtsch Arztebl Int; 2011 Mar; 108(10):163-9. PubMed ID: 21475574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of Survival Time and Other Event Times - What Does the Surgeon Need to Know?].
    Kropf S; Meyer F; Glimm E
    Zentralbl Chir; 2016 Aug; 141(4):383-9. PubMed ID: 25333520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton MR spectroscopy provides relevant prognostic information in high-grade astrocytomas.
    Majós C; Bruna J; Julià-Sapé M; Cos M; Camins A; Gil M; Acebes JJ; Aguilera C; Arús C
    AJNR Am J Neuroradiol; 2011 Jan; 32(1):74-80. PubMed ID: 21030477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A generalized log-rank-type test for comparing survivals with doubly interval-censored data.
    Kim J; Kim YJ; Nam CM
    Biom J; 2009 Aug; 51(4):689-96. PubMed ID: 19650058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear regression analysis: part 14 of a series on evaluation of scientific publications.
    Schneider A; Hommel G; Blettner M
    Dtsch Arztebl Int; 2010 Nov; 107(44):776-82. PubMed ID: 21116397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overestimation of the probability of death on peritoneal dialysis by the Kaplan-Meier method: advantages of a competing risks approach.
    Beuscart JB; Pagniez D; Boulanger E; Lessore de Sainte Foy C; Salleron J; Frimat L; Duhamel A
    BMC Nephrol; 2012 May; 13():31. PubMed ID: 22646159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival Analysis and Interpretation of Time-to-Event Data: The Tortoise and the Hare.
    Schober P; Vetter TR
    Anesth Analg; 2018 Sep; 127(3):792-798. PubMed ID: 30015653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival analysis: part II - applied clinical data analysis.
    In J; Lee DK
    Korean J Anesthesiol; 2019 Oct; 72(5):441-457. PubMed ID: 31096731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential tests for non-proportional hazards data.
    Brückner M; Brannath W
    Lifetime Data Anal; 2017 Jul; 23(3):339-352. PubMed ID: 26969674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.
    Shan Q; Shi J; Wang X; Guo J; Han X; Wang Z; Wang H
    BMC Cancer; 2021 May; 21(1):640. PubMed ID: 34051733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology.
    Horiguchi M; Hassett MJ; Uno H
    Clin Trials; 2020 Dec; 17(6):597-606. PubMed ID: 32933339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the Cox model to the Fine-Gray model for survival analyses of re-fracture rates.
    Nolan EK; Chen HY
    Arch Osteoporos; 2020 Jun; 15(1):86. PubMed ID: 32519193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonparametric inference on median residual life function.
    Jeong JH; Jung SH; Costantino JP
    Biometrics; 2008 Mar; 64(1):157-63. PubMed ID: 17501936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summarizing differences in cumulative incidence functions.
    Zhang MJ; Fine J
    Stat Med; 2008 Oct; 27(24):4939-49. PubMed ID: 18563792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of gastric cancer survival: using an artificial hierarchical neural network.
    Amiri Z; Mohammad K; Mahmoudi M; Zeraati H; Fotouhi A
    Pak J Biol Sci; 2008 Apr; 11(8):1076-84. PubMed ID: 18819544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistics review 12: survival analysis.
    Bewick V; Cheek L; Ball J
    Crit Care; 2004 Oct; 8(5):389-94. PubMed ID: 15469602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consistent estimation of the expected Brier score in general survival models with right-censored event times.
    Gerds TA; Schumacher M
    Biom J; 2006 Dec; 48(6):1029-40. PubMed ID: 17240660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of censored data.
    Lucijanic M; Petrovecki M
    Biochem Med (Zagreb); 2012; 22(2):151-5. PubMed ID: 22838181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience.
    Hughes RT; Masters AH; McTyre ER; Farris MK; Chung C; Page BR; Kleinberg LR; Hepel J; Contessa JN; Chiang V; Ruiz J; Watabe K; Su J; Fiveash JB; Braunstein S; Chao S; Attia A; Ayala-Peacock DN; Chan MD
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1091-1098. PubMed ID: 30959122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A global goodness-of-fit test for receiver operating characteristic curve analysis via the bootstrap method.
    Zou KH; Resnic FS; Talos IF; Goldberg-Zimring D; Bhagwat JG; Haker SJ; Kikinis R; Jolesz FA; Ohno-Machado L
    J Biomed Inform; 2005 Oct; 38(5):395-403. PubMed ID: 16198998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.